Poland has declined Latvia’s offer to purchase unused Covid-19 vaccines, according to information from the Ministry of Health (VM) presented to the government.
In February, Poland informed that it had decided not to buy the adapted Comirnaty (JN.1) vaccines from Latvia, the ministry explained. In line with manufacturer requirements, vaccine prices are not publicly disclosed, the ministry added.
The government will discuss the issue in the closed part of its meeting on Tuesday. Documents prepared by the ministry show that a previous order allowing the sale of vaccines to Poland will be annulled.
As previously reported by LETA,
Poland had considered purchasing Latvia’s unused vaccines.
Last November, during a meeting of the Saeima Budget and Finance (Taxation) Committee, Deputy State Secretary for Financial Affairs at the Ministry of Health, Boriss Kņigins, said the vaccines in question were valued at 2.6 million euros.
At the time, committee deputies questioned ministry representatives about why and for how long Latvia would continue to procure Covid-19 vaccines despite declining domestic demand.
Kņigins explained that the contracts with pharmaceutical manufacturers had been signed by the European Commission on behalf of all member states, and that negotiations with the Commission and manufacturers to terminate or amend these agreements had been unsuccessful. He also noted that deliveries of vaccines would continue until the end of 2026.